OSLO UNIVERSITETSSYKEHUS HF
Kirkeveien 166 Tarnbygget – Oslo – 296
VAT: nan
http://www.oslo-universitetssykehus.no
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, OSLO UNIVERSITETSSYKEHUS HF has received € 2,121,629.0 for its participation in a total of 9 project(s) with a total cost of € 334,678,317.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-01-01 | 847912 | RESCUER | breast cancer | 2024-12-31 | participant | € 935,625.0 | € 6,283,250 | 1 | 17 | CORDIS ↪ |
| 2019-01-01 | 825575 | EJP RD | ecosystems | 2023-12-31 | thirdParty | € 0.0 | € 100,359,517 | 2 | 157 | CORDIS ↪ |
| 2019-10-01 | 859962 | SECRET | proteins · cell polarity · colorectal cancer | 2023-09-30 | participant | € 292,342.32 | € 3,915,871 | 1 | 12 | CORDIS ↪ |
| 2018-01-01 | 800858 | ICEI | neurobiology · data science · software · computational science | 2023-09-30 | participant | € 0.0 | € 50,075,048 | 4 | 163 | CORDIS ↪ |
| 2020-04-01 | 945539 | HBP SGA3 | cognitive neuroscience · databases · revolutions · computational neuroscience · robotics | 2023-09-30 | participant | € 62,500.0 | € 150,000,000 | 4 | 162 | CORDIS ↪ |
| 2019-01-01 | 825821 | iReceptor Plus | autoimmune diseases · vaccines · oncology · personalized medicine · immunotherapy | 2022-12-31 | participant | € 0.0 | € 8,505,675 | 6 | 21 | CORDIS ↪ |
| 2018-06-01 | 765104 | MATURE-NK | pharmaceutical drugs · oncology · personalized medicine · business and management · cells technologies | 2022-11-30 | participant | € 286,275.24 | € 3,347,488 | 1 | 14 | CORDIS ↪ |
| 2016-01-01 | 668596 | ChiLTERN | liver cancer · surgery · hepatology · paediatrics · cardiology | 2021-12-31 | participant | € 107,387.5 | € 8,191,665 | 1 | 30 | CORDIS ↪ |
| 2017-11-01 | 769872 | EMPATHIC | eHealth · public services · demography · psychology · social work | 2021-04-30 | participant | € 437,500.0 | € 3,999,800 | 1 | 12 | CORDIS ↪ |
Showing 1 to 9 of 9 entries
Within the Horizon Europe (2021-2027) framework, OSLO UNIVERSITETSSYKEHUS HF has received € 2,581,813.0 for its participation in a total of 5 project(s) with a total cost of € 48,147,655.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 101136670 | GLIOMATCH | oncology · personalized medicine · machine learning | 2028-12-31 | participant | € 1,069,080.0 | € 11,389,958 | 1 | 15 | CORDIS ↪ |
| 2023-05-01 | 101104582 | IntReALL 2020 | mortality · databases · leukemia | 2028-04-30 | participant | € 111,250.0 | € 6,135,176 | 1 | 26 | CORDIS ↪ |
| 2022-11-01 | 101071203 | SUMO | artificial intelligence · developmental biology · stem cells · physiology | 2027-10-31 | coordinator | € 1,334,843.0 | € 3,438,217 | 1 | 8 | CORDIS ↪ |
| 2023-04-01 | 101104587 | ECHoS | 2026-03-31 | associatedPartner | € nan | € 6,185,678 | 1 | 57 | CORDIS ↪ | |
| 2022-02-01 | 101046133 | ISIDORe | infectious diseases · pandemics · structural biology | 2025-07-31 | participant | € 66,640.0 | € 20,998,624 | 1 | 159 | CORDIS ↪ |
Showing 1 to 5 of 5 entries
Within the FP7 (2007-2013) framework, OSLO UNIVERSITETSSYKEHUS HF has received € 642,300.0 for its participation in a total of 3 project(s) with a total cost of € 20,405,978.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-10-01 | 278514 | INTREALL | drug discovery · mortality · databases · leukemia | 2017-09-30 | participant | € 102,300.0 | € 7,763,823 | 1 | 29 | CORDIS ↪ |
| 2011-01-01 | 260600 | GLYCOHIT | biosensors · virology · proteins · oncology · spectroscopy | 2014-06-30 | participant | € 90,600.0 | € 4,874,903 | 1 | 15 | CORDIS ↪ |
| 2009-12-01 | 242210 | FIGHT-MG | proteomics · satellite technology · stem cells · epigenetics | 2014-05-31 | participant | € 449,400.0 | € 7,767,250 | 3 | 12 | CORDIS ↪ |
Showing 1 to 3 of 3 entries